Skip to main content
Helping Pay Your Medicine

At Bristol-Myers Squibb, we are firmly focused on our Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. In addition, we are steadfast in our Commitment to economic, social and environmental sustainability.

Integrity is the foundation from which we operate. As a Biopharma leader, we take our responsibilities seriously, and always strive to do the right thing for the benefit of the patients we serve around the world, our company, our employees, our shareholders and our communities.

We know that all too often, patients worldwide face health disparities and barriers to health care. Certain populations – particularly the urban and rural poor, women, racial and ethnic minorities, and marginalized people – experience worse health outcomes compared with others.

Global health care challenges are daunting. We recognize that as we provide innovative medicines for patients in need we must work together with governments, payers, patients, health care providers and other stakeholders to develop workable and sustainable solutions. As part of our Mission to help patients prevail, this is what we do.

Patient Assistance Programme

oasisAllaying concerns, Providing hope.
BMS is committed to helping patients. BMS worldwide conducts several programs to reduce health disparities and to enhance global access to medicine.

Since 2006, BMS in India has rolled out several patient assistance programs in different therapeutic area to support:

  • In providing medicine to eligible individuals.
  • Delivery of medicine to patient’s doorstep without any additional cost.
  • Value Added services such as monthly reminder and educational booklets.
  • The benefit of convenient monthly installments for your therapy.


Partnering with Patients and Physicians to Enhance Access and Improve Compliance: Working Locally to Help Patients Get the Medicines They Need

Bristol-Myers Squibb has developed a number of market-specific initiatives in India to expand access to its medicines and make them more affordable. For example, programs offer special incentives to refill drug prescriptions for certain products.

The company uses a third-party M/s Kartavya Healtheon Private Limited, patient support agency, to manage certain patient-related efforts, including programs to improve compliance and medicine availability for hepatitis B and CML patients. In these programs, the Oasis agency delivers medicines to patients and also provides disease education materials and counseling services. Patient support materials are translated into nine languages other than English. In addition, screening camps in India are supported by Bristol-Myers Squibb to uncover cases of hepatitis B.

For more information on our Patient Support/Assistance Programme in India, please get in touch with OASIS call center services. These services are available only to eligible patients under the criteria set down by BMS in India.

If you have any queries about the program, please feel free to contact Oasis center at


© 2015 Bristol-Myers Squibb Company Legal Notice   »   Privacy Policy   »  Trademarks